https://www.selleckchem.com/products/q-vd-oph.html
Regardless of great progress in early detection of hepatocellular carcinoma (HCC), unresectable HCC (uHCC) still accounts for the majority of newly diagnosed HCC with poor prognosis. With the promising results of a double combination of transarterial chemembolization) and tyrosine kinase inhibitors (TKIs), and TKIs and immune checkpoint inhibitors (ICIs), a more aggressive strategy, a triple combination of transarterial chemembolization), TKIs, and ICIs has been tried in the recent years. Hence, we aimed to conduct a systematic rev
Like
Comment
Share
